375 related articles for article (PubMed ID: 34888848)
41. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive analysis of long noncoding RNA-mRNA co-expression patterns in thyroid cancer.
Du Y; Xia W; Zhang J; Wan D; Yang Z; Li X
Mol Biosyst; 2017 Sep; 13(10):2107-2115. PubMed ID: 28817151
[TBL] [Abstract][Full Text] [Related]
43. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
[TBL] [Abstract][Full Text] [Related]
44. Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer.
Ma B; Liao T; Wen D; Dong C; Zhou L; Yang S; Wang Y; Ji Q
Sci Rep; 2016 Nov; 6():36973. PubMed ID: 27833134
[TBL] [Abstract][Full Text] [Related]
45. Identification of potential LncRNAs as papillary thyroid carcinoma biomarkers based on integrated bioinformatics analysis using TCGA and RNA sequencing data.
Feng JL; Zheng WJ; Xu L; Zhou QY; Chen J
Sci Rep; 2023 Mar; 13(1):4350. PubMed ID: 36928327
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
47. Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting 131I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases.
Qiu ZL; Shen CT; Sun ZK; Wei WJ; Zhang XY; Song HJ; Luo QY
Cell Physiol Biochem; 2016; 40(6):1377-1390. PubMed ID: 27997908
[TBL] [Abstract][Full Text] [Related]
48. MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer.
Zhou J; Xu M; Tan J; Zhou L; Dong F; Huang T
Front Oncol; 2022; 12():1030590. PubMed ID: 36479070
[TBL] [Abstract][Full Text] [Related]
49. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract][Full Text] [Related]
50. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value.
Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J
Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.
Tan J; Liu L; Zuo Z; Song B; Cai T; Ding D; Lu Y; Ye X
Oncol Rep; 2020 Oct; 44(4):1489-1501. PubMed ID: 32945494
[TBL] [Abstract][Full Text] [Related]
52. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
[TBL] [Abstract][Full Text] [Related]
53. Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma.
Pu W; Shi X; Yu P; Zhang M; Liu Z; Tan L; Han P; Wang Y; Ji D; Gan H; Wei W; Lu Z; Qu N; Hu J; Hu X; Luo Z; Li H; Ji Q; Wang J; Zhang X; Wang YL
Nat Commun; 2021 Oct; 12(1):6058. PubMed ID: 34663816
[TBL] [Abstract][Full Text] [Related]
54. Expression and Function of Long Noncoding RNA NONHSAT129183 in Papillary Thyroid Cancer.
Ding J; Wang F; Xiang T; Qiao M
Oncol Res; 2018 Aug; 26(7):1047-1053. PubMed ID: 29321094
[TBL] [Abstract][Full Text] [Related]
55. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
56. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
57. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
59. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
[TBL] [Abstract][Full Text] [Related]
60. Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429.
Wu WJ; Yin H; Hu JJ; Wei XZ
Neoplasma; 2018 Nov; 65(6):933-942. PubMed ID: 29940766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
